External broker reports(aggregated public sources), HDFC Securities

HDFC Securities

HDFC securities is the best online trading platform for stocks, IPOs, mutual fund in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

HDFC securities is the best online trading platform for stocks, IPOs, mutual fund in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>Mastek reported an in-line revenue performance (+2.1% QoQ, flat organic) while the margin was below estimate</li><li>The muted organic growth was due to continued pressure in NHS and weak UK financial services offset by growth in the UK government and Middle East business (Manufacturing)</li><li>The UK government pipeline remains strong but decision-making is slow and NHS revival is taking longer than expected (recovery timelines have shifted to FY25E)</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Mastek reported an in-line revenue performance (+2.1% QoQ, flat organic) while the margin was below estimateThe muted organic growth was due to continued pressure in NHS and weak UK financial services offset by growth in the UK government and Middle East business (Manufacturing)The UK government pipeline remains strong but decision-making is slow and NHS revival is taking longer than expected (recovery timelines have shifted to FY25E)Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Mastek Ltd

Mastek - Growth Recovery